鹏华中证中药ETF联接A(016891)申购赎回 |
|
|
| 报告期 |
期初总份额(份) |
期末总份额(份) |
期间总申购份额(份) |
期间总赎回份额(份) |
期间净申赎份额(份) |
净申赎比例 |
| 2025/12/31 |
62,041,200 |
77,135,700 |
43,143,700 |
28,049,200 |
15,094,500 |
24.33% |
| 2025/9/30 |
45,252,600 |
62,041,200 |
36,428,500 |
19,640,000 |
16,788,500 |
37.1% |
| 2025/6/30 |
35,742,100 |
45,252,600 |
30,668,800 |
21,158,200 |
9,510,600 |
26.61% |
| 2025/6/30 |
43,609,500 |
45,252,600 |
14,612,500 |
12,969,500 |
1,643,000 |
3.77% |
| 2025/3/31 |
35,742,100 |
43,609,500 |
16,056,200 |
8,188,730 |
7,867,470 |
22.01% |
| 2024/12/31 |
23,805,200 |
35,742,100 |
46,674,100 |
34,737,300 |
11,936,800 |
50.14% |
| 2024/12/31 |
32,268,600 |
35,742,100 |
20,318,900 |
16,845,500 |
3,473,400 |
10.76% |
| 2024/9/30 |
25,729,100 |
32,268,600 |
13,161,200 |
6,621,670 |
6,539,530 |
25.42% |
| 2024/6/30 |
23,805,200 |
25,729,100 |
13,194,000 |
11,270,100 |
1,923,900 |
8.08% |
| 2024/6/30 |
24,708,800 |
25,729,100 |
8,210,170 |
7,189,830 |
1,020,340 |
4.13% |
| 2024/3/31 |
23,805,200 |
24,708,800 |
4,983,870 |
4,080,320 |
903,550 |
3.8% |
| 2023/12/31 |
39,783,300 |
23,805,200 |
25,795,300 |
41,773,400 |
-15,978,100 |
-40.16% |
| 2023/12/31 |
21,856,900 |
23,805,200 |
5,617,490 |
3,669,160 |
1,948,330 |
8.91% |
| 2023/9/30 |
21,372,500 |
21,856,900 |
5,914,870 |
5,430,440 |
484,430 |
2.27% |
| 2023/6/30 |
39,783,300 |
21,372,500 |
14,263,000 |
32,673,800 |
-18,410,800 |
-46.28% |
| 2023/6/30 |
30,316,700 |
21,372,500 |
8,646,700 |
17,590,900 |
-8,944,200 |
-29.5% |
| 2023/3/31 |
39,783,300 |
30,316,700 |
5,616,250 |
15,082,900 |
-9,466,650 |
-23.8% |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。
